ERCC1/RAD10 (Tumor Progression Marker) Monoclonal Antibody (ERCC1/7597), NeoBiotechnologies™
Mouse Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
ERCC1/RAD10 (Tumor Progression Marker)
Concentration
200 μg/mL
Classification
Monoclonal
Form
Liquid
Regulatory Status
RUO
Formulation
PBS with 0.5% BSA and 0.5% sodium azide
Gene Alias
COFS4; DNA excision repair protein ERCC-1; ERCC excision repair 1, endonuclease non-catalytic subunit; Ercc1; Ercc-1; excision repair cross-complementation group 1; excision repair cross-complementing 1; excision repair cross-complementing rodent repair deficiency, complementation group 1; excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence); hypothetical protein LOC405807; RAD10; UV20; zgc:77511
Immunogen
Recombinant fragment (around aa 191-281) of human ERCC1 protein (exact sequence is proprietary)
Primary or Secondary
Primary
Content And Storage
4° C
Gene
ERCC1
Clone
ERCC1/7597
Applications
Immunohistochemistry (Paraffin)
Conjugate
Unconjugated
Host Species
Mouse
Target Species
Human
Gene Accession No.
P07992
Gene ID (Entrez)
2067
Isotype
IgG1 κ
Purification Method
Protein A/G
Product Type
Antibody
Related Products
Description
- Positive Control:HeLa or HepG2 cells
- Human tonsil or prostate
- Cellular Location: Nucleus
- ERCC1/RAD10 (Tumor Progression Marker) Monoclonal antibody specifically detects ERCC1/RAD10 (Tumor Progression Marker) in Human samples
- It is validated for Immunohistochemistry (Paraffin)